Dr. Bernhard Klemen spent more than 10 years at UBS, Morgan Stanley and J.P. Morgan in London and Frankfurt as well as Vienna, where he established the Austrian J.P. Morgan business. Since 2011 he has been a business angel and first investor as well as co-founder of more than 25 companies with scalable business models in tech and biotech. Between 2017-18 he became co-founder and raised, as international partner, the first international venture capital fund with a Pakistan focus - Sarmayacar. In 2018 he became an investor and board advisor supporting fundraising efforts for bit.bio before joining the company's executive team as CFO in 2021.
bit.bio, the cell coding company, today announces the appointment of Dr Michael Booth as Senior Vice President, External Affairs and Investor Relation
We are very pleased to welcome Mike to the bit.bio senior leadership team. As a proven investor relations leader with excellent capital markets relationships on both sides of the Atlantic, Mike will immediately broaden our network and strengthen our communications with both current and new investors as we continue to execute our mission to code cells for novel cures.